SYNOPSYS INCSNPS
SYNOPSYS INC Financial Overview 2021–2025
The $35.0 billion acquisition of Ansys completely reshaped Synopsys in FY2025, transforming the semiconductor design firm into a comprehensive systems powerhouse while driving long-term debt to $14.3 billion. This massive capital deployment underlines the core investment thesis: Synopsys is securing absolute dominance in AI-driven electronic design automation, even as it absorbs heavy integration costs to widen its competitive moat.
Top-line expansion has been consistent over the reporting period, with total revenue scaling from $4.2 billion in FY2021 to $7.1 billion in FY2025. The Ansys merger alone contributed $756.6 million during the final year. However, the legacy business navigated severe geopolitical headwinds, as the Design IP segment suffered a 22% revenue drop in China (excluding Ansys) due to export control restrictions and reduced demand from a key foundry customer. To streamline its operational focus and manage a newly leveraged balance sheet, Synopsys divested its Software Integrity unit for up to $2.1 billion and suspended its stock repurchase program, closing the year with $3.0 billion in cash.
Investors have priced in high expectations for this newly combined entity. By the close of FY2025, the market valued the company at an $84.4 billion market cap, with shares priced at $453.82 and trading at a steep 56.4x earnings multiple.
Recent Developments (Q3 and Q4 2025)
Synopsys secured a major strategic partnership in Q4 2025, with NVIDIA purchasing 4,821,717 shares for $2 billion at $414.79 per share. To drive post-merger efficiencies, the company announced a 10% workforce reduction, expected to incur $300 million to $350 million in restructuring charges. Leadership also shifted as Chief Revenue Officer Rick Mahoney departed abruptly. Earlier in Q3 2025, total revenue rose 14% year-over-year to $1.74 billion. However, operating expenses jumped 35% to $1.6 billion, pushing net income down to $242.5 million from $408.1 million the previous year.
Bulls view the NVIDIA equity injection as powerful validation of Synopsys' central role in AI hardware development. Conversely, bears highlight margin pressure from integration costs and two newly filed shareholder class action lawsuits, making the stock appear richly priced at 59.9x earnings as of December 21, 2025.
What to watch: appointment of a new Chief Revenue Officer; execution of the corporate restructuring plan through FY2026
Rev
$7.05B
FY2025
NI
$1.33B
FY2025
EPS
$8.13
FY2025
OCF
$1.52B
FY2025
Year-over-year comparison from 10-K annual reports
Data from SEC Company Facts
Recent SEC Filings
SYNOPSYS INC 8-K Report, Financial Results (Dec 10, 2025)
Synopsys, Inc. (SNPS) has filed an 8-K report on December 9, 2025, to announce its financial results for the fourth fiscal quarter and the full fiscal year ended October 31, 2025. The report primarily incorporates a press release, dated December 10, 2025, which contains the detailed financial outcomes. Investors should refer to this press release, furnished as Exhibit 99.1, for specific figures regarding revenue, earnings, and other key performance indicators for the reported periods. This filing serves as a notification and does not include extensive commentary beyond what is presented in the press release itself, but it is the official channel for disseminating this crucial financial information.
SYNOPSYS INC 8-K Report, Unregistered Securities Sale (Dec 1, 2025)
Synopsys, Inc. (SNPS) announced today, December 1, 2025, a significant strategic development involving NVIDIA Corporation. Synopsys has entered into a Securities Purchase Agreement with NVIDIA, through which NVIDIA has acquired 4,821,717 shares of Synopsys common stock for a total of $2 billion in cash. This transaction was conducted as a private placement, exempt from public registration under Section 4(a)(2) of the Securities Act of 1933. This $2 billion investment from a major industry player like NVIDIA signifies strong confidence in Synopsys's technology and future prospects. The investment is expected to provide Synopsys with substantial capital to fuel its growth initiatives, research and development, and strategic objectives. Investors should note that this is an unregistered sale of equity, meaning these shares were not offered to the general public through a registered offering.
SYNOPSYS INC 8-K Report, Exit or Disposal Costs (Nov 12, 2025)
Synopsys, Inc. (SNPS) has announced a significant restructuring plan, approved by its Board of Directors on November 9, 2025, involving the termination of approximately 10% of its workforce. This move is strategically positioned to facilitate investment in key growth areas and enhance business efficiencies, particularly in the context of its recently completed acquisition of ANSYS, Inc. The company anticipates pre-tax charges between $300 million and $350 million related to severance, termination benefits, and facility closures. The majority of these workforce reductions are expected to occur during fiscal year 2026, with substantial completion targeted by the end of fiscal year 2027, subject to local regulations and consultation processes. Investors should monitor the impact of these charges on near-term financial results and the long-term realization of operational efficiencies.
SYNOPSYS INC 8-K Report, Executive Changes (Nov 4, 2025)
Synopsys Inc. (SNPS) has filed an 8-K report on November 4, 2025, announcing a key executive change and reaffirming its financial outlook. Effective immediately, Rick Mahoney has stepped down as Chief Revenue Officer, and the company is in the final stages of searching for his replacement, with an announcement expected soon. This leadership transition in a critical revenue-generating role warrants investor attention as the company works to ensure continuity and stability in its sales operations.
SYNOPSYS INC 8-K/A Report, Executive Changes (Sep 18, 2025)
This 8-K/A filing from Synopsys Inc. (SNPS) is an amendment to a previous report detailing changes to its Board of Directors and committees. The primary update is the appointment of Mr. Vijayaraghavan to the Corporate Governance and Nominating Committee, effective September 17, 2025. This follows his initial appointment to the Board of Directors on July 17, 2025. For investors, this indicates continued board refreshment and focus on governance matters. The committee role suggests Mr. Vijayaraghavan will be involved in the oversight of board composition, director nominations, and corporate governance policies, which are crucial for long-term company health and shareholder value.
View all 8-K filings →